TARDBP and amyotrophic lateral sclerosis: Notably, when examining whether targeting hATXN2 could influence the aggregation of ALS-linked TDP-43 protein variants, we observed that inclusions for the TDP-43 variant TDP-43A315T were more effectively reduced than those for TDP-43G298S or TDP-43M337V.